The FDA adds a new boxed warning for immune effector cell-associated enterocolitis with Carvykti, but says the overall ...
Ciltacabtagene autoleucel (cilta-cel; Carvykti) for multiple myeloma has a new boxed warning for immune effector ...
FDA updates Johnson & Johnson's Carvykti label to warn of rare immune-related enterocolitis while reaffirming the therapy's ...
Food and Drug Administration on Friday approved labeling changes for Johnson & Johnson and its partner Legend Biotech's blood ...
The U.S. Food and Drug Administration (FDA) has updated the safety labeling for Carvykti, the multiple myeloma therapy ...